MedPath

The trend of rise and fall of circulating DNA after the first cycle of chemotherapy in breast cancer patients

Not Applicable
Completed
Conditions
Health Condition 1: null- patients with breast cancer receiving chemotherapy
Registration Number
CTRI/2015/09/006195
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

1.Patients with histopathologically confirmed breast cancer

2.Patients with early, locally advanced or metastatic breast cancer who are planned for some type of chemotherapy.

3.Patients who are willing to participate in the study including blood sampling at the defined time points

EXCLUSION CRITERIA:patients with diabetes and autoimmune disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath